Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orchard Therapeutics plc - American Depositary Shares (NQ:ORTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orchard Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 Next >
Orchard Therapeutics Announces Comprehensive Presence at 19th Annual WORLDSymposium
Four oral presentations and 11 posters highlight transformative potential of HSC gene therapy and newborn screening to address severe neurometabolic diseases 
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
Orchard Therapeutics Highlights Recent Progress Across HSC Gene Therapy Portfolio and Outlines Key 2023 Milestones
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics: Q1 Earnings Insights
Orchard Therapeutics (NASDAQ:ORTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Orchard Therapeutics Q4 Earnings
  Orchard Therapeutics (NASDAQ:ORTX) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products... 
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
Global registrational trial expected to commence in the second half of 2023 
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces Promising Early Neurocognitive Outcomes from Ongoing Proof-of-concept Study of OTL-201 in MPS-IIIA
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces Swissmedic Validation of the Marketing Authorization Application for Libmeldy (atidarsagene autotemcel)
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics to Present at Multiple Investor Conferences in November 2022
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics to Webcast Conference Call of Third Quarter 2022 Financial Results
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
Company to host KOL conference call and webcast on Monday, December 12 at 5:00 p.m. EST 
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket
Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. 
Via Benzinga
Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas
From Orchard Therapeutics (Europe) Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million. 
Via Benzinga
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
Orchard Therapeutics Earnings Preview
Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Executives Buy More Than $1.5M Of 3 Penny Stocks
US crude oil futures traded higher this morning. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022
Upgrades 
Via Benzinga
Orchard Therapeutics Plans To Seek Strategic Options For Immunodeficiency Programs, Cuts Workforce
Orchard Therapeutics plc (NASDAQ: ORTX) announced its  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.